Clinical Trial Update: This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity, reactogenicity, and safety of co-administered routine infant vaccines with GSK's liquid HRV compared to lyophilized HRV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Hiberix (Haemophilus influenzae type b conjugate vaccine)
• Pediarix (DTaP-HepB-IPV combination vaccine)
• Prevnar 13 (pneumococcal conjugate vaccine)
• Rotavirus Vaccine (HRV) liquid (human rotavirus vaccine, live attenuated)
• Rotavirus Vaccine (Lyophilized) (human rotavirus vaccine, live attenuated)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rotavirus Infection, Rotavirus Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2019-10-31